Blocking of the Endothelin System: The Development of Receptor Antagonists

ISSN： 1094-5539

Source： Pulmonary Pharmacology & Therapeutics, Vol.11, Iss.2, 1998-04, pp. : 97-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical development of endothelin receptor antagonists

By Douglas S.A.

Trends in Pharmacological Sciences, Vol. 18, Iss. 11, 1997-11 ,pp. : 408-413

Elsevier

Access to resources Recommend Favorite

Recent discovery and development of endothelin receptor antagonists

By Wu C.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1653-1668

Informa Healthcare

Access to resources Recommend Favorite

Development of endothelin receptor antagonists as potential therapeutic agents

By Ergul Adviye

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 33-44

Informa Healthcare

Access to resources Recommend Favorite

Endothelin Receptor Antagonists - An Overview

Current Medicinal Chemistry, Vol. 9, Iss. 5, 2002-03 ,pp. : 549-575

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1537-1552

Informa Healthcare

Access to resources Recommend Favorite